Key result
Ultra-early robot-assisted adrenalectomy under ECMELLA support rescues refractory pheochromocytoma crisis and restores cardiac function.
Why the study?
Pheochromocytoma crisis can cause refractory cardiogenic shock leaving patients too unstable for definitive surgical tumor removal.
Case Report (n=1)
Ultra-early robot-assisted adrenalectomy under ECMELLA support is a feasible and potentially life-saving strategy for highly selected patients with refractory pheochromocytoma crisis and cardiogenic shock.
Answers are grounded in this paper and cite their sources.
May support rescue adrenalectomy under ECMELLA in selected refractory crises; leaves open prospective validation before practice change.
Pheochromocytoma crisis is a rare but life-threatening condition that may present with refractory cardiogenic shock and malignant arrhythmias. In this setting, the patient is often too unstable for surgery, although tumor removal remains the only definitive treatment. We report the case of a 57-year-old woman with an adrenal mass who developed a fulminant catecholaminergic crisis after high-dose glucocorticoid administration for contrast allergy prophylaxis. She presented with severe metabolic acidosis (pH 6.98, lactate 14.8 mmol/L), flash pulmonary edema, and acute catecholamine-induced cardiomyopathy with a Takotsubo pattern (LVEF 25%). Initial support with Impella CP was insufficient due to electrical storm and hypermetabolic state. Mechanical support was escalated to combined veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and Impella (ECMELLA). Because of persistent instability, ultra-early robot-assisted adrenalectomy was performed under full mechanical support. The patient was successfully weaned from Impella on postoperative day (POD) 1 and from ECMO on POD5, with progressive cardiac recovery (LVEF 35% at POD14). To our knowledge, this is one of the first (or the first) reported cases of robot-assisted adrenalectomy performed under full ECMELLA support without prior durable hemodynamic stabilization, suggesting a potential role for this strategy in highly selected patients with refractory pheochromocytoma crisis. It also underscores glucocorticoids as a critical and underrecognized trigger.
No takes yet. Share an insight, caveat, or question.
Gioia et al. (2026) conducted a case report in Fulminant pheochromocytoma crisis (n=1). Ultra-early robot-assisted adrenalectomy under ECMELLA support was evaluated on Survival and cardiac recovery. Ultra-early robot-assisted adrenalectomy under full ECMELLA support successfully treated a refractory pheochromocytoma crisis triggered by glucocorticoids, leading to progressive cardiac recovery.
Synapse has enriched 10 related papers. Consider them for comparative context: